AIP
PMVP icon

Ameritas Investment Partners’s PMV Pharmaceuticals PMVP Stock Holding History

Ameritas Investment Partners’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,772
Closed -$6.41K – 3210
2024
Q1 		$6.41K Hold
3,772
– – ﹤0.01% 2911
2023
Q4 		$11.7K Hold
3,772
– – ﹤0.01% 2798
2023
Q3 		$23.2K Buy
3,772
+1,010
+37% +$6.94K ﹤0.01% 2475
2023
Q2 		$17.3K Hold
2,762
– – ﹤0.01% 2634
2023
Q1 		$13.2K Hold
2,762
– – ﹤0.01% 2622
2022
Q4 		$22.2K Hold
2,762
– – ﹤0.01% 2520
2022
Q3 		$32K Hold
2,762
– – ﹤0.01% 2270
2022
Q2 		$39K Buy
2,762
+705
+34% +$10.3K ﹤0.01% 2149
2022
Q1 		$43K Hold
2,057
– – ﹤0.01% 2143
2021
Q4 		$48K Hold
2,057
– – ﹤0.01% 2155
2021
Q3 		$61K Hold
2,057
– – ﹤0.01% 2024
2021
Q2 		$70K Buy
2,057
+913
+80% +$30.5K ﹤0.01% 1962
2021
Q1 		$38K Hold
1,144
– – ﹤0.01% 2244
2020
Q4 		$70K Buy
+1,144
New +$44.9K ﹤0.01% 1780

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ameritas Investment Partners's PMVP Position: Q2 2024 in Review

Ameritas Investment Partners sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 3,772 shares — an estimated $6.41K sold.

Ameritas Investment Partners first reported a position in PMVP in Q4 2020 and held it in 14 quarters. The position peaked at $70K in Q2 2021. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Ameritas Investment Partners reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,772 PMV Pharmaceuticals shares in Q2 2024, an estimated $6.41K.
  • Ameritas Investment Partners first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • Ameritas Investment Partners's PMV Pharmaceuticals position peaked at $70K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.